CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
Active TMS stimulation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03281629
NCT03281629N/ACompleted
CompareCT.gov

Circuitry-Guided Smoking Cessation in Schizophrenia

University of Maryland, Baltimore·interventional·Posted Sep 13, 2017·Updated Jan 18, 2023

In Brief

A clinical study evaluating Active TMS stimulation and Sham TMS stimulation for Smoking Cessation and 2 related conditions. Completed, enrolled 44 participants across 1 site.

Detailed Summary

In a double-blinded, randomized, parallel controlled design, patients with schizophrenia spectrum disorder will be exposed to active or sham repetitive transcranial magentic stimulation (TMS) which was guided by functional magnetic resonance image (MRI). Smoking reduction/cessation and brain functional connectivity changes will be assessed at baseline, different stages of rTMS and/or follow-ups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation, Nicotine Addiction, Schizophrenia
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 13, 2017
Enrollment StartOct 19, 2018
Primary CompletionFeb 28, 2021
Study CompletionFeb 15, 2022
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 8.8 years ago

Interventions

Active TMS stimulationdevice

Multiple trains of active transcranial magnetic stimulation in a day, for multiple days.

Sham TMS stimulationdevice

Multiple trains of sham transcranial magnetic stimulation in a day, for multiple days.